phosphoric acid has been researched along with Coronary Disease in 1 studies
phosphoric acid: concise etchant is 37% H3PO4
phosphoric acid : A phosphorus oxoacid that consists of one oxo and three hydroxy groups joined covalently to a central phosphorus atom.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taniguchi, K | 1 |
| Kakuta, H | 1 |
| Tomura, Y | 1 |
| Kaku, S | 1 |
| Uchida, W | 1 |
1 review available for phosphoric acid and Coronary Disease
| Article | Year |
|---|---|
[Pharmacological and clinical profile of bixalomer (Kiklin(®) capsules): a new therapeutic agent for hyperphosphatemia].
Topics: Animals; Capsules; Chelating Agents; Clinical Trials, Phase III as Topic; Coronary Disease; Humans; | 2013 |